Work

Clinical characteristics, antimicrobial susceptibility, and 30-day mortality among patients with Acinetobacter junii isolates: a multicenter retrospective cohort study

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background To describe the clinical characteristics and 30-day mortality among hospitalized patients with Acinetobacter junii isolates and to characterize the antimicrobial susceptibility and multidrug resistance (MDR) of these isolates. Methods We conducted a multicenter retrospective cohort study at three tertiary hospitals in China from 2020 to 2024. All A. junii isolates were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. We summarized clinical characteristics and antimicrobial susceptibility profiles. Multivariable logistic regression was used to identify factors associated with MDR and 30-day mortality. Results Among 432 patients with A. junii isolates, respiratory specimens accounted for 255 isolates (59.0%), and 202 patients (46.8%) were classified as having infection. Resistance exceeded 30% for cefotaxime, ceftazidime, trimethoprim-sulfamethoxazole, and gentamicin. MDR was present in 169 isolates (39.1%), and 90 isolates (20.8%) were carbapenem resistant. Male sex, clinical infection, prior antimicrobial exposure, central venous catheterization, and urine or wound, drain, or catheter specimen sources were independently associated with MDR. Forty-three patients (10.0%) died within 30 days. An Acute Physiology and Chronic Health Evaluation II score greater than 10 was strongly associated with 30-day mortality. Conclusions A. junii was recovered most often from respiratory specimens, and its clinical significance varied by specimen source. MDR was common, whereas 30-day mortality was associated mainly with acute illness severity.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7237202534
Cites: 24
Cited by:
Related to: 10